References
- Lindhout, D. and Schmidt, D. (1986) In-utero exposure to valproate and neural tube defects. Lancet, 1, 1392-1393.
- Williams, G., King, J., Cunningham, M., Stephan, M., Kerr, B. and Hersh, J.H. (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev. Med. Child. Neurol., 43, 202-206. https://doi.org/10.1017/S001216220100038X
- Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Yang, S.I., Cheong, J.H., Shin, C.Y. and Ko, K.H. (2011) The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats. Toxicol. Lett., 201, 137-142. https://doi.org/10.1016/j.toxlet.2010.12.018
- Schneider, T. and Przewlocki, R. (2005) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology, 30, 80-89. https://doi.org/10.1038/sj.npp.1300518
- Valicenti-McDermott, M., McVicar, K., Rapin, I., Wershil, B.K., Cohen, H. and Shinnar, S. (2006) Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. J. Dev. Behav. Pediatr., 27, S128-S136. https://doi.org/10.1097/00004703-200604002-00011
- Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C. and Tildon, J.T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr., 135, 559-563. https://doi.org/10.1016/S0022-3476(99)70052-1
- Wasilewska, J., Jarocka-Cyrta, E. and Kaczmarski, M. (2009) [Gastrointestinal abnormalities in children with autism]. Pol. Merkuriusz Lek., 27, 40-43.
- Wakefield, A.J., Murch, S.H., Anthony, A., Linnell, J., Casson, D.M., Malik, M., Berelowitz, M., Dhillon, A.P., Thomson, M.A., Harvey, P., Valentine, A., Davies, S.E. and Walker-Smith, J.A. (1998) Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet, 351, 637-641. https://doi.org/10.1016/S0140-6736(97)11096-0
- Horvath, K. and Perman, J.A. (2002) Autistic disorder and gastrointestinal disease. Curr. Opin. Pediatr., 14, 583-587. https://doi.org/10.1097/00008480-200210000-00004
- Sousa, I., Clark, T.G., Toma, C., Kobayashi, K., Choma, M., Holt, R., Sykes, N.H., Lamb, J.A., Bailey, A.J., Battaglia, A., Maestrini, E. and Monaco, A.P. (2009) MET and autism susceptibility: family and case-control studies. Eur. J. Hum. Genet., 17, 749-758. https://doi.org/10.1038/ejhg.2008.215
- Ashwood, P., Anthony, A., Pellicer, A.A., Torrente, F., Walker-Smith, J.A. and Wakefield, A.J. (2003) Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J. Clin. Immunol., 23, 504-517. https://doi.org/10.1023/B:JOCI.0000010427.05143.bb
- Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B. and Krajmalnik-Brown, R. (2013) Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, e68322. https://doi.org/10.1371/journal.pone.0068322
- Baron-Cohen, S. (2002) The extreme male brain theory of autism. Trends Cognit. Sci., 6, 248-254. https://doi.org/10.1016/S1364-6613(02)01904-6
- Kim, K.C., Kim, P., Go, H.S., Choi, C.S., Park, J.H., Kim, H.J., Jeon, S.J., Dela Pena, I.C., Han, S.H., Cheong, J.H., Ryu, J.H. and Shin, C.Y. (2013) Male-specific alteration in excitatory post-synaptic development and social interaction in prenatal valproic acid exposure model of autism spectrum disorder. J. Neurochem., 124, 832-843. https://doi.org/10.1111/jnc.12147
- Mittelstadt, S.W., Hemenway, C.L. and Spruell, R.D. (2005) Effects of fasting on evaluation of gastrointestinal transit with charcoal meal. J. Pharmacol. Toxicol. Methods, 52, 154-158. https://doi.org/10.1016/j.vascn.2005.04.017
- Marathe, P.H., Wen, Y., Norton, J., Greene, D.S., Barbhaiya, R.H. and Wilding, I.R. (2000) Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br. J. Clin. Pharmacol., 50, 325-332.
- Chaturvedi, A., Kumar, M.M., Bhawani, G., Chaturvedi, H., Kumar, M. and Goel, R.K. (2007) Effect of ethanolic extract of Eugenia jambolana seeds on gastric ulceration and secretion in rats. Indian J. Physiol. Pharmacol., 51, 131-140.
- D'Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E. and Giardini, O. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr., 85, 1076-1079. https://doi.org/10.1111/j.1651-2227.1996.tb14220.x
- Lindstrom, L.H., Nyberg, F., Terenius, L., Bauer, K., Besev, G., Gunne, L.M., Lyrens, S., Willdeck-Lund, G. and Lindberg, B. (1984) CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis. Am. J. Psychiatry, 141, 1059-1066. https://doi.org/10.1176/ajp.141.9.1059
- Dignass, A.U., Lynch-Devaney, K. and Podolsky, D.K. (1994) Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem. Biophys. Res. Commun., 202, 701-709. https://doi.org/10.1006/bbrc.1994.1987
- Matsuno, M., Shiota, G., Umeki, K., Kawasaki, H., Kojo, H. and Miura, K. (1997) Induction of plasma hepatocyte growth factor in acute colitis of mice. Inflammation Res., 46, 166-167. https://doi.org/10.1007/s000110050161
- Ido, A., Numata, M., Kodama, M. and Tsubouchi, H. (2005) Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol., 40, 925-931. https://doi.org/10.1007/s00535-005-1705-x
- Russo, A.J., Krigsman, A., Jepson, B. and Wakefield, A. (2009) Decreased Serum Hepatocyte Growth Factor (HGF) in Autistic Children with Severe Gastrointestinal Disease. Biomarker Insights, 4, 181-190.
- Campbell, D.B., Buie, T.M., Winter, H., Bauman, M., Sutcliffe, J.S., Perrin, J.M. and Levitt, P. (2009) Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics, 123, 1018-1024. https://doi.org/10.1542/peds.2008-0819
- Akimoto, M., Baba, A., Ikeda-Matsuo, Y., Yamada, M.K., Itamura, R., Nishiyama, N., Ikegaya, Y. and Matsuki, N. (2004) Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus. Neuroscience, 128, 155-162. https://doi.org/10.1016/j.neuroscience.2004.06.031
- Tyndall, S.J. and Walikonis, R.S. (2006) The receptor tyrosine kinase Met and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle, 5, 1560-1568. https://doi.org/10.4161/cc.5.14.2918
- Gutierrez, H., Dolcet, X., Tolcos, M. and Davies, A. (2004) HGF regulates the development of cortical pyramidal dendrites. Development, 131, 3717-3726. https://doi.org/10.1242/dev.01209
- Ido, A., Numata, M., Kodama, M. and Tsubouchi, H. (2005) Mucosal repair and growth factors: recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J. Gastroenterol, 40, 925-931. https://doi.org/10.1007/s00535-005-1705-x
- Wakefield, A.J., Anthony, A., Murch, S.H., Thomson, M., Montgomery, S.M., Davies, S., O'Leary, J.J., Berelowitz, M. and Walker-Smith, J.A. (2000) Enterocolitis in children with developmental disorders. Am. J. Gastroenterol, 95, 2285-2295. https://doi.org/10.1111/j.1572-0241.2000.03248.x
- Torrente, F., Anthony, A., Heuschkel, R.B., Thomson, M.A., Ashwood, P. and Murch, S.H. (2004) Focal-enhanced gastritis in regressive autism with features distinct from Crohn's and Helicobacter pylori gastritis. Am. J. Gastroenterol., 99, 598-605. https://doi.org/10.1111/j.1572-0241.2004.04142.x
Cited by
- Exploring the Validity of Valproic Acid Animal Model of Autism vol.24, pp.4, 2015, https://doi.org/10.5607/en.2015.24.4.285
- Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia vol.10, pp.1, 2017, https://doi.org/10.1186/s13041-017-0292-0
- RECURRENT GASTRIC POLYPOSIS IN A PATIENT USING ANTIEPILEPTIC DRUGS FOR A LONG TIME vol.40, pp.2, 2017, https://doi.org/10.1097/SGA.0000000000000281